Your browser doesn't support javascript.
loading
Rebleeding in peptic ulcer bleeding - a nationwide cohort study of 19,537 patients.
Laursen, Stig B; Stanley, Adrian J; Laine, Loren; Schaffalitzky de Muckadell, Ove B.
Afiliação
  • Laursen SB; Department of Gastroenterology, Odense University Hospital, Odense C, Denmark.
  • Stanley AJ; Department of Clinical Research, University of Southern Denmark, Odense C, Denmark.
  • Laine L; Department of Gastroenterology, Walton Building, Glasgow Royal Infirmary, Glasgow, UK.
  • Schaffalitzky de Muckadell OB; Section of Digestive Diseases, Yale School of Medicine, New Haven, CT, USA.
Scand J Gastroenterol ; 57(12): 1423-1429, 2022 12.
Article em En | MEDLINE | ID: mdl-35853234
ABSTRACT

BACKGROUND:

Rebleeding is a frequent complication of peptic ulcer bleeding (PUB). The associated prognosis remains rather unclear because previous studies generally also included non-ulcer lesions.

OBJECTIVE:

We aimed to identify predictors for rebleeding; clarify the prognostic consequence of rebleeding; and develop a score for predicting rebleeding.

METHODS:

Nationwide cohort study of consecutive patients presenting to hospital with PUB in Denmark from 2006-2014. Logistic regression analyses were used to identify predictors for rebleeding, evaluate the association between rebleeding and 30-day mortality, and develop a score to predict rebleeding. Patients with persistent bleeding were excluded.

RESULTS:

Among 19,258 patients (mean age 74 years, mean ASA-score 2.4), 10.8% rebled, and 10.2% died. Strongest predictors for rebleeding were endoscopic high-risk stigmata of bleeding (Odds Ratio (OR) 2.12 [95% Confidence Interval (CI) 1.91-2.36]), bleeding from duodenal ulcers (OR 1.87 [95% CI 1.69-2.08]), and presentation with hemodynamic instability (OR 1.55 [95% CI 1.38-1.73]). Among patients with all three factors (7.9% of total), 24% rebled, 50% with rebleeding failed endoscopic therapy, and 23% died. Rebleeding was associated with increased mortality (OR 2.04 [95% CI 1.78-2.32]). We were unable to develop an accurate score to predict rebleeding.

CONCLUSION:

Rebleeding occurs in ∼10% of patients with PUB and is overall associated with a two-fold increase in 30-day mortality. Patients with hemodynamic instability, duodenal ulcers, and high-risk endoscopic stigmata are at highest risk of rebleeding. When rebleeding occurs in such patients, consultation with surgery and/or interventional radiology should be obtained prior to repeat endoscopy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemostase Endoscópica / Úlcera Duodenal Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemostase Endoscópica / Úlcera Duodenal Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article